Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Speaking of Pohl

May 21, 2007 10:06AM

May 21, 2007 11:58AM

May 21, 2007 02:24PM

May 21, 2007 04:04PM

May 21, 2007 04:06PM

and his sweetheart deal to obtain 1,500,000 shares.

Under the terms of the Agreement, the Company granted Mr. Pohl the right, privilege and option ("Option") to purchase 1,500,000 shares of the common stock of the Company at an exercise price of $0.165 per share. The Option was fully vested upon grant and must be exercised within the earlier of (i) August 15, 2007, or (ii) three months after the first date that Mr. Pohl is no longer an officer or director of the Company. The Option's exercise price can be paid (a) in cash or certified bank or cashier's check, (b) in securities of the Company having a fair market value equal to the exercise price, (c) by cashless exercise, or (d) any combination of the above. Mr. Pohl will have no rights as a stockholder with respect to any stock underlying the Option until the date of issuance of a certificate for such stock.

We all have investment goals right? What do you think Pohl is expecting out of his 1.5 million shares? Will something happen byAugust 15th??

$2.00 x 1,500,000. = 3 million

$4.00 x 1,500,000. = 6 million

$6.00 x 1,500,000. = 9 million

How much do you suppose he is looking for to carry him through his golden years?

Watch out for the overall market tomorrow, I believe it is headed south.

Another question: in the event of a Forgent type end to this thing. Do patent plaintiffs ever appeal rulings that go against their patents?


May 21, 2007 09:14PM

May 21, 2007 11:41PM
Share
New Message
Please login to post a reply